Assessment of tumor necrosis factor superfamily member 10 (TNFSF10) gene variants in systemic lupus erythematosus patients

Harraz, 2016, Mannose binding lectin 2 promotor-221 X/Y gene polymorphism in Egyptian systemic lupus erythematosus patients, Egyptian Rheumatologist, 38, 301, 10.1016/j.ejr.2016.03.005 Gheita, 2021, Egyptian College of Rheumatology. Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint, Lupus, 30, 1526, 10.1177/09612033211014253 White, 2003, Apoptosis in systemic lupus erythematosus, CurrOpin Rheumatologist, 15, 557 Nasr, 2016, Expression of Toll–like receptors 3 and 9 in Egyptian systemic lupus erythematosus patientsExpression der Toll‑like‑Rezeptoren3 und 9 bei ägyptischen Patienten mit systemischem Lupuserythematodes, Z Rheumatol, 75, 502, 10.1007/s00393-015-0022-x Gheita, 2012, Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease, J Clin Immunol, 32, 1279, 10.1007/s10875-012-9743-7 Bassiouni, 2021, Programmed death 1 (PD-1) serum level and gene expression in recent onset systemic lupus erythematosus patients, Egyptian Rheumatol, 43, 213, 10.1016/j.ejr.2021.02.005 Lub-de Hooge, 2005, Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus, Ann Rheum Dis, 64, 854, 10.1136/ard.2004.029058 Wiley, 1995, Identification and characterization of a new member of the TNF family that induces apoptosis, Immunity, 3, 673, 10.1016/1074-7613(95)90057-8 Nomura, 2007, Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation, Transpl Immunol, 18, 115, 10.1016/j.trim.2007.05.012 Azkalany, 2012, Clinical significance of serum TNFα and -308 G/A promoter polymorphism and serum Il-6 and -174 G/C promoter polymorphism in systemic lupus erythematosus patients, Egyptian Rheumatologist, 34, 119, 10.1016/j.ejr.2012.05.003 Wang, 2003, TRAIL and apoptosis induction by TNF-family death receptors, Oncogene, 22, 8628, 10.1038/sj.onc.1207232 Höfle, 2022, Engagement of TRAIL triggers degranulation and IFNγ production in human natural killer cells, EMBO Rep, 23, e54133, 10.15252/embr.202154133 Komatsuda, 2007, Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus, Clin Immunol, 125, 26, 10.1016/j.clim.2007.05.019 El-Karaksy, 2013, TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients, Gene, 527, 211, 10.1016/j.gene.2013.05.084 Nguyen, 2009, TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects, Clin Immunol, 132, 32, 10.1016/j.clim.2009.02.011 Luo, 2015, Genetic polymorphisms and haplotypes of TRAIL gene correlate with NSCLC susceptibility in a group of Chinese patients, Int J Clin Exp Med, 8, 16223 Yan, 2009, sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease, Immunogenetics, 61, 551, 10.1007/s00251-009-0389-4 Petri, 2012, Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum, 64, 2677, 10.1002/art.34473 Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum, 35, 630, 10.1002/art.1780350606 Petri, 1991, Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study, Arthritis Rheum, 34, 937, 10.1002/art.1780340802 Soleimani, 2015, Tumor necrosis factor-related apoptosis-inducing ligand gene polymorphisms and hepatitis B virus infection, Jundishapur J Microbiol, 8, e23578, 10.5812/jjm.23578 Stojan, 2018, Epidemiology of systemic lupus erythematosus: an update, CurrOpinRheumatol, 30, 144 Margery Muir, 2017, Gender balance in patients with systemic lupus erythematosus, Autoimmun Rev, 16, 258, 10.1016/j.autrev.2017.01.007 Wang, 2016, Association of polymorphisms in TRAIL and chronic hepatitis B in Chinese Han populations from Shandong Province, Annals of Clin Lab Sci, 46, 374 Sandoughi, 2020, The Impact of TRAIL (C1595T and G1525A) and DR4 (rs20576) Gene Polymorphisms on Systemic Lupus Erythematosus, Biochem Genet, 58, 649, 10.1007/s10528-020-09966-x Yu, 2018, Association between C1q, TRAIL, and Tim-1 gene polymorphisms and systemic lupus erythematosus, Genet Test Mol Biomarkers, 22, 546, 10.1089/gtmb.2018.0056 Savill, 2002, A blast from the past: clearance of apoptotic cells regulates immune responses, Nat Rev Immunol, 2, 965, 10.1038/nri957 McHugh, 2002, Systemic lupus erythematosus and dysregulated apoptosis—what is the evidence?, Rheumatology, 41, 242, 10.1093/rheumatology/41.3.242 Falschlehner, 2009, Following TRAIL’s path in the immune system, Immunology, 127, 145, 10.1111/j.1365-2567.2009.03058.x Kemter, 2005, Molecular cloning, expression analysis and assignment of the porcine tumor necrosis factor superfamily member 10 gene (TNFSF10) to SSC13q34→ q36 by fluorescence in situ hybridization and radiation hybrid mapping, Cytogen Genome Res, 111, 74, 10.1159/000085673 Wei, 2005, Current understanding on the immunological functions of tumor necrosis factor-related apoptosis-inducing ligand, Cell Mol Immunol, 2, 265 Liabakk, 2002, Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA, J Immunol Meth, 259, 119, 10.1016/S0022-1759(01)00501-4 Truneh, 2000, Temperature-sensitive differential affinity of TRAIL for its receptors: DR5 is the highest affinity receptor, J Biol Chem, 275, 23319, 10.1074/jbc.M910438199 Cardoso Alves, 2021, The multifaceted role of TRAIL signaling in cancer and immunity, FEBS J, 288, 5530, 10.1111/febs.15637 Rus, 2002, Expression of cytokine-and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array, Clin Immunol, 102, 283, 10.1006/clim.2001.5182 Bennett, 2003, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J Exp Med, 197, 711, 10.1084/jem.20021553 Matsuyama, 2004, TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus, Blood, 104, 184, 10.1182/blood-2003-12-4274 Khalifa, 2017, Digging more in the genetic risk prediction of hepatitis C virus epidemic in Egypt: Apoptosis genes polymorphisms in the susceptibility of hepatitis C virus and association with viral load, Virus Res, 238, 35, 10.1016/j.virusres.2017.05.025 Hu, 2015, Association of ulcerative colitis with TNF-related apoptosis inducing ligand (TRAIL) gene polymorphisms and plasma soluble TRAIL levels in Chinese Han population, Eur Rev Med Pharmacol Sci, 19, 467 Xu, 2015, Correlation between polymorphism of TRAIL gene and condition of intervertebral disc degeneration, Medical Science Monitor: Int Med J Exp Clin Res, 21, 2282, 10.12659/MSM.894157